The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Locus Ceruleus Degeneration Promotes Alzheimer Pathogenesis in Amyloid Precursor Protein 23 Transgenic Mice
Open accessAbstract
Locus ceruleus (LC) degeneration and loss of cortical noradrenergic innervation occur early in Alzheimer’s disease (AD). Although this has been known for several decades, the contribution of LC degeneration to AD pathogenesis remains unclear. We induced LC degeneration with N-(2-chloroethyl)-N-ethyl-bromo-benzylamine (dsp4) in amyloid precursor protein 23 (APP23) transgenic mice with a low amyloid load. Then 6 months later the LC projection areas showed a robust elevation of glial inflammation along with augmented amyloid plaque deposits. Moreover, neurodegeneration and neuronal loss significantly increased. Importantly, the paraventricular thalamus, a nonprojection area, remained unaffected. Radial arm maze and social partner recognition tests revealed increased memory deficits while high-resolution magnetic resonance imaging-guided micro-positron emission tomography demonstrated reduced cerebral glucose metabolism, disturbed neuronal integrity, and attenuated acetylcholinesterase activity. Nontransgenic mice with LC degeneration were devoid of these alterations. Our data demonstrate that the degeneration of LC affects morphology, metabolism, and function of amyloid plaque-containing higher brain regions in APP23 mice. We postulate that LC degeneration substantially contributes to AD development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, lesioning of another projection pathway, that from the locus coeruleus, was reported to increase plaque pathology in terminal fields of the cerebral cortex [72].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly
Beckman, J. S., & Koppenol, W. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.5.c1424 · Cited by 5,513
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Buckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., Sheline, Y. I., Klunk, W. E., Mathis, C. A., Morris, J. C., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2177-05.2005 · Cited by 2,140
Nucleus locus ceruleus: new evidence of anatomical and physiological specificity
Foote, S. L., Bloom, F. E., & Aston-Jones, G. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.3.844 · Cited by 1,901
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Self-citationWidespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Zarow, C., Lyness, S. A., Mortimer, J. A., & Chui, H. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.337 · Cited by 1,003
Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
Chapman, P. F., White, G. L., Jones, M. W., Cooper-Blacketer, D., Marshall, V. J., Irizarry, M., Younkin, L., Good, M. A., Bliss, T. V. P., Hyman, B. T., et al. (1999) · Nature Neuroscience · doi:10.1038/6374 · Cited by 946
Research works printed but not linked: 1
- (1994), Pharmacopsychiatry, 27, 11
Cited by
Sorted by citations
Items 201–300 of 305
Hippocampal Network Alterations in Alzheimer's Disease and Down Syndrome: From Structure to Therapy
Sanchez, M. M., Moghadam, S., Naik, P. K., Martin, K. J., & Salehi, A. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-0050 · Cited by 17
Lithgow, B., Dastgheib, Z. A., Anssari, N., Mansouri, B., Blakley, B. W., Ashiri, M., & Moussavi, Z. (2021) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-021-02409-8 · Cited by 16
Wang, Y., Musich, P. R., Serrano, M. A., Zou, Y., Zhang, J., & Zhu, M. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9421-4 · Cited by 15
Noradrenergic pathways of locus coeruleus in Parkinson’s and Alzheimer’s pathology
Singh, S. (2019) · International Journal of Neuroscience · doi:10.1080/00207454.2019.1667799 · Cited by 17
Motta, C., Assogna, M., Bonomi, C. G., Lorenzo, F. D., Nuccetelli, M., Mercuri, N. B., Koch, G., & Martorana, A. (2023) · European Journal of Neurology · doi:10.1111/ene.15691 · Cited by 15
Park, C., Ryu, H.-W., & Ryu, K. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.063 · Cited by 15
Pisani, F., Pisani, V., Arcangeli, F., Harding, A., & Singhrao, S. K. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20021007 · Cited by 16
Role of frameshift ubiquitin B protein in Alzheimer's disease
Chen, X., & Petranović, D. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1340 · Cited by 14
Jackisch, R., Gansser, S., & Cassel, J. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.06.011 · Cited by 14
Age-dependent changes in noradrenergic locus coeruleus system in wild-type and APP23 transgenic mice
Szot, P., Dam, D. V., White, S. S., Franklin, A., Staufenbiel, M., & Deyn, P. P. D. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.07.055 · Cited by 14
Self-citationDuffy, K. B., Ray, B., Lahiri, D. K., Tilmont, E. M., Tinkler, G. P., Herbert, R. L., Greig, N. H., Ingram, D. K., Ottinger, M. A., & Mattison, J. A. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180487 · Cited by 13
Malatt, C., & Tagliati, M. (2022) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001042 · Cited by 12
Cortes-Flores, H., Torrandell-Haro, G., & Brinton, R. D. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1358568 · Cited by 12
A possible pathway to freezing of gait in Parkinson's disease
Factor, S. A., Weinshenker, D., & McKay, J. L. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x241308487 · Cited by 12
Aghakhanyan, G., Galgani, A., Vergallo, A., Lombardo, F. P., Martini, N., Baldacci, F., Tognoni, G., Leo, A., Guidoccio, F., Siciliano, G., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.11.002 · Cited by 13
Singh, A., Gupta, P., Tiwari, S., Mishra, A., & Singh, S. (2022) · Cell and Tissue Research · doi:10.1007/s00441-021-03570-0 · Cited by 12
RetractedTang, Y., Cao, M., Li, Y., Lin, Y., Wu, X., Chen, M., Initiative, A. D. N., & Shen, J. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad137 · Cited by 12
Assessing disease-modifying effects of norepinephrine in Down syndrome and Alzheimer’s disease
Ponnusamy, R., McNerney, M. W., Moghadam, S., & Salehi, A. (2017) · Brain Research · doi:10.1016/j.brainres.2017.09.035 · Cited by 11
Lopez‐Picon, F. R., Kirjavainen, A. K., Forsback, S. J., Helin, J. S., Peters, D., Haaparanta‐Solin, M., & Solin, O. H. (2018) · Theranostics · doi:10.7150/thno.29740 · Cited by 11
Pilski, A., & Graves, S. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713039 · Cited by 10
Current Conceptual View of Alzheimer’s Disease
Herrup, K. (2012) · Advances in biological psychiatry · doi:10.1159/000335378 · Cited by 10
Singhaarachchi, P. H., Antal, P., Calon, F., Culmsee, C., Delpech, J.-C., Feldotto, M., Geertsema, J., Hoeksema, E. E., Kőrösi, A., Layé, S., et al. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102821 · Cited by 13
Imaging noradrenergic influence on amyloid pathology in mouse models of Alzheimer’s disease
Winkeler, A., Waerzeggers, Y., Klose, A., Monfared, P., Thomas, A. V., Schubert, M., Heneka, M. T., & Jacobs, A. H. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0710-0 · Cited by 8
Self-citationItoi, K., Ohara, S., & Kobayashi, K. (2013) · Advances in pharmacology · doi:10.1016/b978-0-12-411512-5.00008-7 · Cited by 9
Bupropion and Citalopram in the APP23 Mouse Model of Alzheimer's Disease: A Study in a Dry-Land Maze
Neumeister, K. L., & Riepe, M. W. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/673584 · Cited by 9
Galgani, A., Lombardo, F. P., Frijia, F., Martini, N., Tognoni, G., Pavese, N., & Giorgi, F. S. (2024) · Brain Structure and Function · doi:10.1007/s00429-024-02797-1 · Cited by 9
Le, L., O’Banion, M. K., & Majewska, A. K. (2024) · Scientific Reports · doi:10.1038/s41598-024-81910-0 · Cited by 8
Locus Coeruleus and Noradrenergic Pharmacology in Neurodegenerative Disease
Matt, R. A., Martin, R. S., Evans, A. K., Gever, J. R., Vargas, G. A., Shamloo, M., & Ford, A. P. D. W. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_677 · Cited by 11
High-Resolution Small Animal Imaging
Schäfers, K. P., Bolwin, K., Büther, F., Hermann, S., Jacobs, A. H., Kösters, T., Kuhlmann, M. T., Schäfers, M. A., & Viel, T. (2014) · Elsevier eBooks · doi:10.1016/b978-0-444-53632-7.00110-6 · Cited by 8
Self-citationHurko, O., Boudonck, K. J., Gonzales, C., Hughes, Z. A., Jacobsen, J. S., Reinhart, P. H., & Crowther, D. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/864625 · Cited by 8
Effects of Antidepressants on DSP4/CPT-Induced DNA Damage Response in Neuroblastoma SH-SY5Y Cells
Wang, Y., Hilton, B., Cui, K., & Zhu, M. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9534-z · Cited by 8
Animal Models of Alzheimer’s Disease
Amram, S., & Frenkel, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00003-x · Cited by 8
Okamoto, K., Amari, M., Fukuda, T., Suzuki, K., & Takatama, M. (2017) · Neuropathology · doi:10.1111/neup.12367 · Cited by 8
Gibbs, M. E., & Gibbs, C. L. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.10.070 · Cited by 8
Betts, M. J., Ehrenberg, A. J., Hämmerer, D., & Düzel, E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00401 · Cited by 8
Noradrenaline Regulation of Brain-Body Communication
Fernandes, G., Lam, R. M., Park, J. H., Drummond, G. T., & Sur, M. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-89525-8_2 · Cited by 8
Zhang, K., Zhu, Y. W., Fenik, P., Fleysh, D., Ly, C., THOMAS, S. A., & Veasey, S. C. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.1929-23.2024 · Cited by 8
Beckers, E., Egroo, M. V., Ashton, N. J., Blennow, K., Vandewalle, G., Zetterberg, H., Poser, B. A., & Jacobs, H. I. L. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhae261 · Cited by 9
Jackson, W. S., Bauer, S., Kaczmarczyk, L., & Magadi, S. S. (2024) · Biology · doi:10.3390/biology13020067 · Cited by 8
Neurotoxin-Induced DNA Damage is Persistent in SH-SY5Y Cells and LC Neurons
Wang, Y., Musich, P. R., Cui, K., Zou, Y., & Zhu, M. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9521-4 · Cited by 7
Locus coeruleus ablation in mice: protocol optimization, stereology and behavioral impact
Markussen, N. B., Knopper, R. W., Hasselholt, S., Skoven, C. S., Nyengaard, J. R., Østergaard, L., & Hansen, B. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1138624 · Cited by 6
Knopper, R. W., Skoven, C. S., Eskildsen, S. F., Østergaard, L., & Hansen, B. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1498133 · Cited by 7
Locus coeruleus integrity correlates with plasma soluble Axl levels in Alzheimer's disease patients
Galgani, A., Mary, A., Lombardo, F. P., Martini, N., Scotto, M., Tognoni, G., Siciliano, G., Ceravolo, R., Giorgi, F. S., & Heneka, M. T. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70434 · Cited by 4
Self-citationDifferent Patterns of Locus Coeruleus MRI Alteration in Alzheimer’s and Dementia with Lewy Bodies
Galgani, A., Palermo, G., Lombardo, F. P., Martini, N., Bastiani, L., Vergallo, A., Tommasini, L., Bellini, G., Baldacci, F., Frosini, D., et al. (2023) · Current Alzheimer Research · doi:10.2174/1567205020666230721144603 · Cited by 5
Fading Blue: Exploring the Causes of Locus Coeruleus Damage Across the Lifespan
Galgani, A., Scotto, M., Faraguna, U., & Giorgi, F. S. (2025) · Antioxidants · doi:10.3390/antiox14030255 · Cited by 7
Neuropsychiatric Profiles and Cerebral Amyloid Burden in Adults without Dementia
Gontrum, E. Q., Paolillo, E. W., Lee, S. Y., Diaz, V., Ehrenberg, A. J., Saloner, R., Mundada, N. S., Joie, R. L., Rabinovici, G. D., Kramer, J. H., et al. (2024) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000538376 · Cited by 5
Engels, N., Koops, E. A., Hsieh, S., Wiklund, E. E., Schultz, A. P., Riphagen, J. M., Prokopiou, P. C., Hanseeuw, B. J., Rentz, D. M., Sperling, R. A., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01500-0 · Cited by 5
Motor activity in young APPswe + PS1/A246E bigenic mice as a predicting variable for memory decline
Filali, M., & Lalonde, R. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23552 · Cited by 4
The locus coeruleus, a blue spot for early diagnosis and prognosis of Alzheimer’s disease
Farahani, F., Anaclet, C., Azizi, H., & Gompf, H. S. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1632236 · Cited by 4
Stapleton, H. M., Borges, D. D. S., Trindade, E. B. S. D. M., & Yuan, Q. (2026) · Biology of Sex Differences · doi:10.1186/s13293-026-00834-8 · Cited by 3
Korukonda, A., Blankenship, H. E., Kam, K., Kour, D., Espinosa‐García, C., Jang, W. E., Srivastava, U., Mulvey, B., Tish, M. M., Witztum, R., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03852-5 · Cited by 4
The Value of the Object Recognition Paradigm in Investigating Animal Models of Alzheimer's Disease
Mathis, C. (2018) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-812012-5.00021-5 · Cited by 3
Neurodegenerative Dementias: Improving Brain Health to Decrease Risk
Bateman, J. R., Hurley, R. A., & Taber, K. H. (2019) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.18110287 · Cited by 3
The Involvement of Melatonin and Tasimelteon against Alzheimer’s Disease
Ravikumar, M., Mohan, S., & Velpandian, C. (2022) · Current Drug Safety · doi:10.2174/1574886317666220517125644 · Cited by 4
Tuska, R., Helm, S. M., Graf, C. F., James, C., Kong, G., Stiemsma, L. T., Green, D. B., & Helm, S. E. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1060212 · Cited by 4
Sakai, T., Hattori, S., Ogata, A., Yamada, T., Abe, J., Ikenuma, H., Ichise, M., Suzuki, M., Ito, K., Kato, T., et al. (2023) · EJNMMI Research · doi:10.1186/s13550-023-01032-y · Cited by 3
Herholz, K. (2008) · Springer eBooks · doi:10.1007/978-88-470-0840-3_33 · Cited by 3
Sleep Loss and Neuronal Stress
Naidoo, N. N. (2019) · Springer eBooks · doi:10.1007/978-981-13-2814-5_3 · Cited by 3
Grigoryan, G., Lonnemann, N., & Körte, M. (2019) · Neural Plasticity · doi:10.1155/2019/3152129 · Cited by 3
Positron Emission Tomography in Animal Models of Alzheimer’s Disease AmyloidosisPreprint
Ni, R. (2021) · Preprints.org · doi:10.20944/preprints202110.0222.v1 · Cited by 2
Engel, S., Dillerud, M., Scalf, M., Dobbelmann, R., Du, Y., Lee, A. M., & Graves, S. M. (2025) · Alcohol · doi:10.1016/j.alcohol.2025.05.004 · Cited by 2
Impact of early locus coeruleus lesions in the TgF344 Alzheimer's disease rat model
Marriott, A., Schroeder, J. P., Korukonda, A., Pate, B. S., McCann, K. E., Weinshenker, D., & Kelberman, M. A. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71334 · Cited by 2
Heneka, M. T. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.013 · Cited by 2
Self-citationUnique Pathology in the Locus Coeruleus of Individuals with Down Syndrome
Saternos, H., Hamlett, E. D., Guzman, S. J., Head, E., Granholm, A., & Ledreux, A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240043 · Cited by 2
Galgani, A., Scotto, M., & Giorgi, F. S. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46090607 · Cited by 3
Taniuchi, N., Niidome, T., & Sugimoto, H. (2015) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.14-00226 · Cited by 2
Norepinephrine in Neurodegeneration: A Coerulean Target
Vazey, E. M. (2012) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000e114 · Cited by 2
Neuroinflammation in Alzheimer's Disease
(2020) · Case Medical Research · doi:10.31525/ct1-nct04274998 · Cited by 2
Stress, stress systems, and Alzheimer's disease
Eberly, S. G., Phumsatitpong, C., Munro, C. E., Neylan, T. C., Kaufer, D., & Ehrenberg, A. J. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71542 · Cited by 1
Managing microglia in Alzheimer's
Osherovich, L. Z. (2010) · Science-Business eXchange · doi:10.1038/scibx.2010.423 · Cited by 1
Validation of Dementia Models Employing Neuroimaging Techniques
Vanhoutte, G., Campo, A., & der Linden, A. V. (2010) · Neuromethods · doi:10.1007/978-1-60761-898-0_11 · Cited by 1
Puckett, O. K., Fennema‐Notestine, C., Hagler, D. J., Braskie, M. N., Chen, J., Finch, C. E., Kaufman, J. D., Petkus, A. J., Reynolds, C. A., Salminen, L. E., et al. (2024) · Environmental Health Perspectives · doi:10.1289/ehp14344 · Cited by 2
Applications of Small-Animal Imaging in Neurology and Psychiatry
Casteels, C., Zaidi, H., & Laere, K. V. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0894-3_19 · Cited by 1
Galgani, A., & Giorgi, F. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824010-6.00049-6 · Cited by 1
AD‐Type Neuron Loss in Transgenic Mouse Models
Manaye, K. F., & Mouton, P. R. (2013) · Wiley eBooks · doi:10.1002/9781118444177.ch13 · Cited by 1
Lesions and Genes: On the Edge of Improved Isomorphic Models for Alzheimer’s Disease?
de Aguilar, J. G., Loeffler, J., & Boutillier, A. (2008) · Neurodegenerative Diseases · doi:10.1159/000135616 · Cited by 1
Majewska, A. K., Le, L., Feidler, A. M., Li, H., Kara-Pabani, K., Lamantia, C. E., & O’Banion, M. K. (2024) · Research Square · doi:10.21203/rs.3.rs-3976896/v1 · Cited by 1
Wang, Y. (2014) · Digital Commons - East Tennessee State University (East Tennessee State University)
UBB+1, an important switch in the onset of Alzheimer’s disease
Gentier, R. J. G. (2015) · Research Publications (Maastricht University) · doi:10.26481/dis.20151105rg
Sindi, S., Rosenberg, A., Juster, R., & LUPIEN, S. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00082-1 · Cited by 1
Sleep, Adenosine, and Neurodegeneration
Bjorness, T. E., & Greene, R. W. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803724-9.00006-5
Feinstein, D. L., & Heneka, M. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805088-0.00016-5
Self-citationKang, S. S., Liu, X., Ahn, E. H., Xiang, J., Manfredsson, F. P., Yang, X., Luo, H. R., Liles, L. C., Weinshenker, D., & Ye, K. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/688200
Klakotskaia, D. (2017) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/63858
Kelberman, M. A., Anderson, C. R., Chlan, E., Rorabaugh, J. M., McCann, K. E., & Weinshenker, D. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.30.466530
Preclinical Longitudinal In Vivo Biomarker Platform for Alzheimer’s Disease Drug Discovery
Kang, M. S., Zimmer, E. R., Ottoy, J., Shin, M., Woo, M. S., Aliaga, A., Massarweh, G., Cuello, A. C., Gauthier, S. G., & Rosa‐Neto, P. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108975759.010
Reduced Norepinephrine Transporter Binding in Parkinson’s disease with dopa Responsive Freezing GaitPreprint
McKay, J. L., Nye, J. A., Goldstein, F. C., Sommerfeld, B., Smith, Y., Weinshenker, D., & Factor, S. A. (2022) · medRxiv · doi:10.1101/2022.03.14.22272365
Hernandez, A. C. M. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3555
Faculty Opinions recommendation of Neuroinflammation in Alzheimer's disease.
Perani, D. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.725413893.793537457
Lim, E. Y., Salinas, A., Ye, L., Yang, Y., & Paukert, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.27.497832
Alzheimer's Disease In Vivo Models: A Traditional Review
TÜTÜNCÜ, S., Yalçın, H. T., ÖZYURT, A. B., Yirün, A., Baydar, T., & Erkekoğlu, P. (2023) · Journal of Literature Pharmacy Sciences · doi:10.5336/pharmsci.2022-90431
The ubiquitin-proteasome system in neurodegenerative diseases
Verheijen, L. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20231024lv · Cited by 1
Apolipoprotein E4 Carriers as Clinical Trial Subjects
Smith, C. J., Ashford, J. W., & Perfetti, T. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_63-1
Heo, E. Y., Salinas‐Birt, A., Ye, L., Sajadi, S., Sarker, M. K., Yang, Y., & Paukert, M. (2025) · iScience · doi:10.1016/j.isci.2025.113120
Sakai, T., Hattori, S., Ogata, A., Yamada, T., Abe, J., Ikenuma, H., Ichise, M., Suzuki, M., Ito, K., Kato, T., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151329
Engels, N., Koops, E. A., Hsieh, S., Wiklund, E. E., Schultz, A. P., Riphagen, J. M., Prokopiou, P. C., Hanseeuw, B. J., Rentz, D. M., Sperling, R. A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26054646
Torrente, D., Su, E. J., Schielke, G. P., Warnock, M., Mann, K. M., & Lawrence, D. A. (2024) · Figshare · doi:10.6084/m9.figshare.26572513
Hernandez, N. M., Silva-Pérez, M. A., & Chin, J. (2026) · PLoS ONE · doi:10.1371/journal.pone.0340611 · Cited by 1
Garland, I. J. Z., Engel, S., Scalf, M., Payne, N. R., Lee, A. M., & Graves, S. M. (2026) · Neurotoxicity Research · doi:10.1007/s12640-026-00794-2
The brainstem in neurodegenerative diseases
Grinberg, L. T. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-443-15736-3.00017-2
Metadata
- Authors
- Heneka, M. T., Ramanathan, M., Jacobs, A. H., Dumitrescu-Ozimek, L., Bilkei-Gorzo, A., Debeir, T., Sastre, M., Galldiks, N., Zimmer, A., Hoehn, M., Heiss, W.-D., Klockgether, T., & Staufenbiel, M.
- Affiliations
- University of Bonn (DE)
- ORCID
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2006-02-01
- Volume
- 26
- Issue
- 5
- Pages
- 1343-1354
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6675491
- OpenAlex
- W2118414216
- Cited by
- 305
- References
- 54
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 18 · 2023: 21 · 2022: 23 · 2021: 18 · 2020: 16 · 2019: 16 · 2018: 12 · 2017: 20 · 2016: 9 · 2015: 17 · 2014: 11 · 2013: 17 · 2012: 19
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion, other-oa)
- Max Planck Institute for Plasma Physics (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (SFB400)
- International Brain Research Organization
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease pathogenesis, glial inflammation, amyloid plaques, neurodegeneration, memory impairment, brain glucose metabolism, acetylcholinesterase activity, paraventricular thalamus, cholinergic hypothesis
- MeSH terms
- Alzheimer Disease, Animals, Astrocytes, Brain, Cognition Disorders, Female, Locus Coeruleus, Mice, Transgenic, Nerve Degeneration, Norepinephrine, Amyloid beta-Protein Precursor, Microglia, Peroxynitrous Acid, Positron-Emission Tomography, Vesicular Acetylcholine Transport Proteins, Mice, Nitric Oxide Synthase Type II, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
